Study to Evaluate the Pharmacokinetics and the Safety of M518101 in Plaque Psoriasis Patients

Evaluate the Safety and Pharmacokinetics/Pharmacodynamics of HS-20118

NCT06846710 ·Status: RECRUITING ·Phase: PHASE1

A Double-blind, Placebo-controlled, Randomized, Parallel-group Study to Evaluate the Activity of Oral AB1010 in Adults Patients With Moderate to Severe Chronic Plaque Psoriasis

NCT01045577 ·Status: COMPLETED ·Phase: PHASE2

A Phase 2 Dose Ranging, Evaluator-Blinded Study to Evaluate the Safety of Topical IDP-118

NCT01670513 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2

A Study to Assess if Mirikizumab is Effective and Safe Compared to Secukinumab and Placebo in Moderate to Severe Plaque Psoriasis (OASIS-2)

NCT03535194 ·Status: COMPLETED ·Phase: PHASE3

Multi-Dose Study of SHR-1314 in Subjects With Moderate-to-severe Plaque Psoriasis

NCT03463187 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Study to Evaluate Efficacy and Safety of MP1032 in Patients With Chronic Plaque Psoriasis

NCT03706209 ·Status: COMPLETED ·Phase: PHASE2

Open-Label Extension Study to Evaluate the Long Term Safety and Efficacy of ESK-001 in Plaque Psoriasis

NCT05739435 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

A Phase 2 Study Investigating the Effect of EDP1815 in the Treatment of Mild to Moderate Plaque Psoriasis

NCT04603027 ·Status: COMPLETED ·Phase: PHASE2

Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Clinical Effects of AMG 557 in Adults With Psoriasis

NCT01493518 ·Status: TERMINATED ·Phase: PHASE1

A Study to Evaluate the Efficacy and Safety of ESK-001 in Patients With Plaque Psoriasis

NCT05600036 ·Status: COMPLETED ·Phase: PHASE2

A Study to Evaluate the Pharmacokinetics, Safety and Tolerability of ABBV-553 in Healthy Volunteers and in Subjects With Psoriasis and Efficacy of ABBV-553 in Subjects With Psoriasis

NCT03145948 ·Status: TERMINATED ·Phase: PHASE1

A Study to Evaluate Efficacy and Safety of HS-10374 for Moderate to Severe Plaque Psoriasis

NCT06077331 ·Status: RECRUITING ·Phase: PHASE2

Efficacy and Safety Study of Two Doses of Apremilast (CC-10004) In Japanese Patients With Moderate-To-Severe Plaque-Type Psoriasis

NCT01988103 ·Status: COMPLETED ·Phase: PHASE2

Study to Compare U0267 Against Vehicle in Subjects With Plaque-type Psoriasis One of Two Phase 3 Studies

NCT00688519 ·Status: COMPLETED ·Phase: PHASE3

Paired Psoriasis Lesion, Comparative, Study to Evaluate MOL4239 in Psoriasis

NCT01826201 ·Status: COMPLETED ·Phase: PHASE2

A Comparison of 188-0551 Solution Versus Vehicle Solution in Subjects With Plaque Psoriasis (Study 203)

NCT03065556 ·Status: COMPLETED ·Phase: PHASE2

Single and Multiple Dose Escalation Study to Assess the Safety and Tolerability of CJM112 in Psoriasis

NCT01828086 ·Status: COMPLETED ·Phase: PHASE1

Efficacy 、Safety and PK of SHR-1314 in Patients With Moderate-to-Severe Plaque Psoriasis

NCT04839016 ·Status: UNKNOWN ·Phase: PHASE3

A Study to Evaluate the Efficacy and Safety of Mirikizumab (LY3074828) in Participants With Moderate-to-Severe Plaque Psoriasis

NCT03482011 ·Status: COMPLETED ·Phase: PHASE3

Comparison of 188-0551 Spray Versus Vehicle Spray in Subjects With Plaque Psoriasis (307)

NCT03731052 ·Status: COMPLETED ·Phase: PHASE3

Mechanism of Action Study for Psoriasis

NCT00932113 ·Status: COMPLETED ·Phase: PHASE4

A Comparison of 188-0551 Spray Versus Vehicle Spray in Subjects With Plaque Psoriasis

NCT03759197 ·Status: COMPLETED ·Phase: PHASE3

Study to Compare U0267 Against Vehicle in Subjects With Plaque-type Psoriasis Two of Two Phase 3 Studies

NCT00689481 ·Status: COMPLETED ·Phase: PHASE3

A Safety and Efficacy Study of Ustekinumab in Patients With Plaque Psoriasis Who Have Had an Inadequate Response to Methotrexate

NCT01059773 ·Status: COMPLETED ·Phase: PHASE4

Study to Evaluate Effectiveness and Safety in Subjects With Moderate to Severe Psoriasis

NCT02931838 ·Status: COMPLETED ·Phase: PHASE2